13 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
affecting our development programs and potential product acquisitions.
Code of Business Conduct and Ethics
The Company currently maintains a Code … of Business Conduct and Ethics which applies to all directors, officers, and employees. A copy of our Code of Business Conduct and Ethics can be found
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
before human clinical trials may begin;
approval by an independent Institutional Review Board (“IRB”) or ethics committee at each clinical site … in each member state in which the clinical trial takes place, to both the competent national health authority and an independent ethics committee, much
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
statutory auditor, (iv) agreed to comply with all policies, codes of conduct, confidentiality obligations and codes of ethics applicable to the Company’s … directors, including the Company’s Code of Business Conduct and Ethics, (v) agreed to provide the information regarding themselves that is required
F-1/A
nrwjatq
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
svxazo9jl bpfr65hx
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
20-F
lglyh6
29 Apr 19
Annual report (foreign)
4:59pm
424B3
acc bvnshj
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
pcrivwt1mjlk38tb
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
EX-10.25
r0lxmtgp2tksl
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
0139wfd uku2rm8w07y
25 Jan 19
Registration of securities (foreign)
12:00am
- Prev
- 1
- Next